Marijuana Stocks Recap & The Road Ahead For GT Biopharma (GTBP)
GT Biopharma has continued to surge an since making several key announcements, GT’s market has been on fire. Have you been paying attention? Ahead of the new month and new trading week, we put togther a special report on a company that has been showing big momentum all summer & could be ready for more during “back to school” season.
Click Here To Read More
Marijuana Stocks & Why You Should Be Watching ETF’s Rebalance
Today we are giving a cliffs notes version of ETF Rebalancing as we are under already under way with this process.
Click Here For More
Top Marijuana Stocks Continue to Surprise Investors
The cannabis market has been full of a large amount of surprise over the course of the past several months to years. With so many new companies coming in and innovating the space, it seems as though cannabis is here for the long haul. Many of the stocks in the market have begun to move into the stratosphere of the cannabis space, and with new partnerships, things only appear to continue growing.
Click Here For Full Release
Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com